Latest Auxilium Pharmaceuticals Inc. Stories
CHESTERBROOK, Pa., Feb. 3, 2015 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc.
LYNBROOK, N.Y., Feb. 2, 2015 /PRNewswire/ -- BioSpecifics Technologies Corp.
DUBLIN, Jan. 29, 2015 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced it has completed the acquisition of Auxilium Pharmaceuticals, Inc.
-- Moves designed to accelerate Endo's continued evolution into a leading global specialty healthcare company -- Changes to reporting structure will support Endo's future growth DUBLIN,
CHESTERBROOK, Pa. and STOCKHOLM, Dec. 22, 2014 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc.
CHESTERBROOK, Pa., Dec. 11, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that it has scheduled a special meeting of its stockholders for 8:30 a.m.
DUBLIN, Dec. 11, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that the U.S.
Erectile Dysfunction Data Presented in Two Moderated Posters; Findings Enable a Better Understanding of the STENDRA Clinical Profile and Provide Additional Data Regarding the Use of STENDRA as Early
Peyronie's Disease Data Presented Enable a Better Understanding of the Safety and Efficacy of XIAFLEX for Treatment of PD; First Data Presented on PD Treatment Impact on Female Partner Sexual Function CHESTERBROOK,
DUBLIN and CHESTERBROOK, Pa., Nov. 19, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) and Auxilium Pharmaceuticals, Inc.